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As a result of the discovery that flavonoids are directly or indirectly connected to
health, flavonoid metabolism and its fascinating molecules that are natural products in
plants, have attracted the attention of both the industry and researchers involved in
plant science, nutrition, bio/chemistry, chemical bioengineering, pharmacy, medicine, etc.
Subsequently, in the past few years, flavonoids became a top story in the pharmaceutical
industry, which is continually seeking novel ways to produce safe and efficient drugs.
Microbial cell cultures can act as workhorse bio-factories by offering their metabolic
machinery for the purpose of optimizing the conditions and increasing the productivity
of a selective flavonoid. Furthermore, metabolic engineering methodology is used to
reinforce what nature does best by correcting the inadequacies and dead-ends of a
metabolic pathway. Combinatorial biosynthesis techniques led to the discovery of novel
ways of producing natural and even unnatural plant flavonoids, while, in addition, metabolic
engineering provided the industry with the opportunity to invest in synthetic biology in
order to overcome the currently existing restricted diversification and productivity issues
in synthetic chemistry protocols. In this review, is presented an update on the rationalized
approaches to the production of natural or unnatural flavonoids through biotechnology,
analyzing the significance of combinatorial biosynthesis of agricultural/pharmaceutical
compounds produced in heterologous organisms. Also mentioned are strategies and
achievements that have so far thrived in the area of synthetic biology, with an emphasis
on metabolic engineering targeting the cellular optimization of microorganisms and
plants that produce flavonoids, while stressing the advances in flux dynamic control and
optimization. Finally, the involvement of the rapidly increasing numbers of assembled
genomes that contribute to the gene- or pathway-mining in order to identify the gene(s)
responsible for producing species-specific secondary metabolites is also considered
herein.
Keywords: flavonoid biosynthesis, unnatural flavonoids, metabolic engineering, dynamic regulation, metabolic
control, secondary metabolites, combinatorial biosynthesis
INTRODUCTION
Flavonoids are known to be produced by all terrestrial plants.
They comprise a large group of natural compounds deriving
from the phenylpropanoid metabolism, which has evolved in
plants to produce a large number of inter-related flavonoid struc-
tures (Figure 1). Various reviews have appeared that describe
in detail the metabolic routes as well as the major and minor
groups that flavonoids fall into (Winkel-Shirley, 2001; Andersen
and Markham, 2006; Ververidis et al., 2007; Gholami et al.,
2014). In the phenylpropanoid metabolism, metabolites branch
out to form specific groups like those presented in Figure 1
(i.e., flavonoids, stilbenoids, lignins, etc.). The name “phenyl-
propanoid” originates from the aromatic phenyl group and the
three-carbon tail of the starting phenylalanine, which is then
bioconverted first to cinnamic acid, and then to p-coumaric
acid (Figure 2). The addition of a coenzyme A group to those
hydroxycinnamic acids activates those molecules for the subse-
quent enzymatic decarboxylation and condensation with three
activated malonyl-CoA molecules. This reaction is catalyzed by
a polyketide III synthase (Chalcone Synthase, CHS) to cre-
ate chalcones, the actual precursor molecules of the flavonoid
backbone.These are then converted to flavanones through the
use of a Chalcone Isomerase (CHI) (Andersen and Markham,
2006). In subsequent steps, diversification is generated by the
sequential action of “decorating” enzymes on the flavonoid
backbone.
Flavonoids seemed to function as internal regulatory agents
(Stafford, 1991), while in later evolutionary stages, they func-
tioned as filters against ultraviolet irradiation (Stapleton and
Walbot, 1994). Such flavonoid producing organisms, with either
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FIGURE 1 | Brief overview of biosynthetic inter-relations between plant
metabolites stemming from Phenylaline (Phe) and Tyrosine (Tyr), which
are derived from shikimic acid (Bennett and Wallsgrove, 1994). Phe and
Tyr act as precursors to the highlighted parts of secondary metabolism
(colored). Emphasis is given to phenylpropanoid metabolism (pale yellow
colored) leading to flavonoids biosynthesis (pale blue colored).
lower or higher cellular complexity, evolved to survive in
hostile environments, in terms of both biotic and abiotic stress
(Demain and Fang, 2000). Moreover, under the pressure of
natural selection, those metabolites, apart from their crucial
role in other physiological functions, also constitute important
parts of the protection mechanisms, either by direct mortifica-
tion or by the inhibition of a certain function of the invad-
ing organism (Bennett and Wallsgrove, 1994). Such natural
plant products that derive from the chorismate and shikimate
pathway of primary metabolism, exhibit an impressive chem-
ical diversity caused by plant evolution (Demain and Fang,
2000). Utilizing the molecular mechanisms of their synthesis
and their beneficial properties for human health (Ververidis
et al., 2007), we will be able to design and create biotech-
nological tools that will further establish our position in the
fields of agriculture and nutrition as well as the pharmaceu-
tical industry, concomitantly promoting consumer health and
protection.
However, the extraction of these molecules from plant
sources does not result in quantities large enough to meet the
increasing market demands. The isolation or purification of
natural products using conventional extraction processes, espe-
cially regarding those intended for commercial use, appears to be
limited due to the low concentration levels of these phytochem-
icals in plants, as opposed to high plant biomass. Furthermore,
these processes are time-consuming, expensive, wasteful in regard
to natural resources and, sometimes, environmentally unsafe due
to the usage of solvents during the isolation and purification
procedures. It has become evident to society, thus attracting the
attention of scientists, that industrial needs demand alternative
extraction platforms, a significant reduction of costs related to
isolation and purification practices and a substantial increase of
availability levels.
Recent advances in microbial biotechnology have significantly
supported the expression of partial or entire metabolic path-
ways, allowing the biosynthesis of high value end-products. In this
project, we review the current metabolic engineering approaches
to achieving exploitable concentrations of natural flavonoid com-
pounds in microorganisms, with potential application in the
industry. We also introduce several research efforts that aim to
produce unnatural flavonoid analogs (non-natively synthesized
by plants) using in vivo approaches.
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FIGURE 2 | Early biosynthetic steps of flavonoid metabolism leading
to the formation of flavonoid groups of Flavanones and Flavones. At
the initial steps, the flavonoid core molecule is produced from the
condensation reaction of activated hydroxinnamic acids with 3 molecules
of Malonyl-CoA (not shown) by the action of chalcone synthase (CHS)
and subsequent isomeration with the enzyme chalcone isomerase (CHI)
for the generation of the flavanone group (Ververidis et al., 2007).
Following the action of flavone synthase I (FNS I) the group of flavones
is produced. 4CL, hydroxycinnamic acid:CoA ligase; CHR, chalcone
reductase; F3′H, flavonoid 3′ hydroxylase; F3′5′H, flavonoid 3′5′
hydroxylase; MT, methyltransferase; GT, glucoside transferase and Sam5:
microbial C3H (Lee et al., 2014). Flavonoids indicated with the same
lettering (A–D) declare components of certain biosynthetic path. (∗)
Dihydrotricetin is produced from naringenin chalcone (A) by the action of
both F3′5′H before the action of CHI, thus it is introduced instead of
naringenin into pathway (D) (Andersen and Markham, 2006).
DIVERSITY OF FLAVONOIDS AS SECONDARY METABOLITES
OF AGRICULTURAL AND/OR PHARMACEUTICAL
IMPORTANCE
Several characteristics distinguish flavonoids and other secondary
metabolites from substances of the primary metabolism. More
specifically: (i) there is a tendency for accumulation in certain
tissues or organs, an example being the flavonols in grape skins
(Mu et al., 2014). (ii) Their distribution is limited to certain tax-
onomic units, as evidenced by the isoflavonoid biosynthesis in
species of the Fabaceae plant family (Reynaud et al., 2005). (iii)
They are developmentally regulated, as made obvious by tissue
cultures that are unable to produce secondary metabolites, even
though the plant cells possess the necessary genetic information
(Wink, 2003). Finally, (iv) they are likely to possess biological
activity e.g., in organism-organism interactions or in organismal
differentiation (Haslam, 1995).
Advancements in metabolomics provided the opportunity to
identify accurately the diverse array of chemicals produced by
organisms. Such diversity, which is the result of the ongoing evo-
lutionary processes, exists not only between different species or
genera but also within the same individual, though not to the
same extent. Structural and molecular biology advances have
revealed that mutation and gene duplication are the processes
responsible for the continuous modifications of the enzymes
involved in the flavonoid biosynthesis (Noel et al., 2005). Such
mechanisms can result in the production of a wide variety
of compounds, due to the action of enzymes and enzyme
complexes on the basic structure of metabolic pathways. The
enzymes involved in flavonoid biosynthetic pathways appear to
have evolved in this way, thus causing catalysis that can lead
either to region-specific condensation or to glycosylation, acy-
lation, prenylation, sulfation, methylation or isomerization. In
that respect, it appears that a flavonoid-producing organism is
able to synthesize a core molecule, such as the flavanone narin-
genin. This molecule is then likely processed downstream by
several classes of enzymes (e.g., hydroxylases, isomerases, etc.,)
in order to form the flavonoid end-products, such as eriodic-
tyol or dihydroxykaempferol [for pathways see Figure 2 of this
review and Figure 3 in Ververidis et al. (2007)]. Moreover, it
is a common feature of many organisms to use enzymes that
can utilize their activity on different kinds of substrates. For
example, the enzyme flavonol synthase catalyzes the oxidation
of flavanonol to flavonol using either dihydrokaempferol or
dihydroquercetin as a substrate, and producing kaempferol or
quercetin respectively. Such mixtures of biosynthesized metabo-
lites result in the formation of chemical shields used either
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to defend or to adapt (Dixon and Paiva, 1995; Harborne and
Williams, 2000).
The question arising is why there is such a chemical diver-
sity. In an attempt to answer this, we will shed light on several
principles of evolutionary biology. Natural selection is the only
explanation for adaptation and it can act on populations only
if there is variation among its members and if such a variation
is random with respect to the direction of adaptation (Jenke-
Kodama et al., 2008). By definition, the extent of genetic diversity
of a population is proportional to the potential of the same popu-
lation to adapt to environmental changes. However, by purposely
extending the meaning of genetic diversity, it can be considered
equal to chemical diversity. According to this principle, pop-
ulations characterized by significant genetic heterogeneity are
consequently also characterized by chemical heterogeneity. This
heterogeneity may be the result of the existence of a large num-
ber of gene alleles that perform the same core chemical reaction
(e.g., C-3 hydroxylation of flavanones). Following this, different
enzyme variants may accept different (similar) substrates and per-
form the same chemical reaction for the production of different
end-products. These individuals are more likely to be preserved
in a changing environment, since a rich genetic stock is more
likely to contain genes that favor the adaptation of individuals
in the new environmental conditions. This idea also agrees with
Firn’s assumption, which states that it is a rare property for any
molecule to possess a potent biological activity. Thus, organisms
have to generate as much chemical variability as possible in order
to increase the probability to find amolecule that fits into a certain
function (Firn and Jones, 2000).
This also provides the potential to produce many different
structures by minimizing genetic resources. If, for example, a
set of seven genes is needed for the production of kaempferol
from phenylalanine, an evolutionary acquired allelic variation
that hydroxylates the C-3′ position of the B flavonoid ring
(i.e., flavonoid 3′hydroxylase; F3′H), will lead the flavonol syn-
thase (FLS) to the production of two flavonols instead of one;
kaempferol and quercetin (Trantas et al., 2009). Similarly, the
expression of a resveratrol synthase (RS) in grapes that has arisen
from a chalcone synthase (CHS) duplication (Rausher, 2006), is
responsible for the production of resveratrol that belongs to a new
class of non-flavonoid phenylpropanoid compounds. Therefore,
it appears that RS and CHS are responsible for the diversification
of phenylpropanoid metabolism leading to the production of stil-
benoids, flavonoids and their descendants respectively (Ververidis
et al., 2007).
Given the large number of organisms and thus the large num-
ber of existing interactions, the number of secondary metabolites
taking part in the adjustment mechanisms is expected to be
extremely high. It is therefore evident that nature is a unique
source of input in the effort to find and create new potent
medicinal products.
FLAVONOID COMBINATORIAL BIOSYNTHESIS OF
AGRICULTURAL/PHARMACEUTICAL IMPORTANCE
Over the past few decades, the inadequate availability of source
materials from which phytochemicals are extracted, as well as
the complexity of the production of these products through
conventional chemical synthesis, resulted in the gradual reduction
of the Pharma- Food- and Agro- industry’s interest in developing
natural product-based commercial applications. It is often com-
mercially unfeasible to synthesize chemically bioactive molecules,
originally produced from plants with some structural complex-
ity combining low cost production and demanding purity. Even
though the chemical synthesis allows targeted design of novel
compounds with improved or even new functions, the metabolic
engineering techniques appears to be gaining grounds (Otero
and Nielsen, 2010). Since natural plant products usually have
no nutritional value but when included in a diet can boost the
immune system or protect the human body from free radicals or
even prevent or suppress carcinogenesis, marketed demand will
continue to peak. Moreover, due to the limited chemical diversity
and structural complexity of chemical synthetic libraries, as well
as due to the great success of natural product-derived drugs on
the market in the past few years, screening of untapped biological
resources for new natural products is expected to be continued in
the future (Marienhagen and Bott, 2013).
Many biosynthetic pathways for natural plant products have
been elucidated through the advancements in DNA sequenc-
ing, in combination with new recombinant DNA technologies.
Furthermore, innovative technologies have emerged relying on
bacterial, yeast or plant cell-based biotransformations targeting
in vivo biosynthesis for the large-scale production of natural
products under controlled conditions, in an attempt to gener-
ate novel natural products, and for the production of rare and
expensive natural products (Mora-Pale et al., 2014). Such pro-
duction strategies are highly specific, fully controlled and do
not contribute to environmental pollution. What is more, the
recovery of the resulting products is considerably easier than
natural product extraction or conventional chemical synthesis,
since fewer side products and less waste is generated. To this
end, industrial biotechnology flourished. Significant work has
been done to generate a broad number of natural products, their
analogs, as well as different classes of useful intermediates such as
isoprenoids, flavonoids, stilbenes, polysaccharides and glycopro-
teins, and alcohols (Abdullah et al., 2008). These substances have
potential applications as pharmaceuticals, fine chemicals and bio-
fuels (Otero and Nielsen, 2010; van Summeren-Wesenhagen and
Marienhagen, 2013).
Since themid-1980’s, advances in genetic engineeringmethod-
ology led to the development of an alternative approach,
described as combinatorial biosynthesis, to generate new
molecules from natural products. The reason for this is that
plants constitute an extremely rich source of bioactive products
that possess a huge potential for drug discovery. Combinatorial
biosynthesis comprises a series of methods that establish novel
enzyme-substrate combinations in vivo that lead to the biosyn-
thesis of new, natural or even unnatural compounds, which can
be used in drug discovery programs (Chemler et al., 2007). The
techniques involved in combinatorial biosynthesis can be sum-
marized into the following categories (Pollier et al., 2011; Cress
et al., 2013): (i) bio-transformation, in which natural or non-
natural compounds are modified by different types of biocatalysts
(whole cells, cell extracts, or purified enzymes); (ii) feeding of
mutated (recombinant) biocatalysts with non-natural precursor
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compounds, the latter leading to mutasynthesis, a semi-synthetic
methodology (Chemler et al., 2007; Bhan et al., 2014); (iii) com-
binatorial metabolism in hybrids that evolved from crossings
within different accessions, cultivars, or genotypes of a single
plant species, or even interspecific sexual or somatic hybridiza-
tion; (iv) activation of silent metabolism through the activation
of relevant transcription factors; and (v) synthetic biology or the
combinatorial compilation of genes in heterologous (plant) hosts.
In this section, we discuss some examples of state-of-the-
art combinatorial biosynthesis methods that have generated
flavonoid molecules from microbial hosts. In that respect, an
important application of metabolic engineering is the pro-
duction of diversified natural compounds. A combinatorial
biosynthesis strategy was developed by Naesby and his cowork-
ers who employed modified eYACs (expressible Yeast Artificial
Chromosomes) for the expression of plant genes in yeast
(Saccharomyces cerevisiae) (Naesby et al., 2009). The use of these
vectors allowed the combined expression of a large number of
genes from various sources intending to function in random
combinations leading to the biosynthesis of various flavonols.
This combinatorial approach resulted in the creation of 5–7 step
variable pathway assemblies, each converting the phenylalanine
and/or tyrosine yeast metabolites into flavonoids, normally only
produced by plants. When randomly picked clones were analyzed,
approximately half of them showcased a production of the fla-
vanone naringenin, and a third of them produced the flavonol
kaempferol in various amounts.
Combinatorial biosynthesis is a method that establishes novel
enzyme-substrate combinations in vivo. Innovative strategies that
combine enzymes that apparently do not function together in
nature, can direct transgenic hosts to the heterologous produc-
tion of rare natural products that do not accumulate in plants
(Fukushima et al., 2013). Consequently, the application of syn-
thetic biology methodologies may result in the development
of new drugs through the combinatorial biosynthesis of plant-
derived natural products (Cress et al., 2013; Gholami et al.,
2014). Such potential has been demonstrated by the production
of diverse flavonoid compounds from microbes when fed with
various natural and unnatural (e.g., halogenated) cinnamic acid
derivatives, that are potentially important to the pharmaceutical
industry (Chemler et al., 2007).
Another reason why flavonoids have become interesting is
because they have been proven to act as microbial deterrents and
anti-infection agents in plants (Trantas et al., 2009). Fowler and
his coworkers, while working trying to increase the flavonoid
effectiveness against some infections by enabling the transport
of a toxic molecule into the infecting species, demonstrated that
combinatorial synthesis of non-natural flavanones could iden-
tify novel anti-microbial agents with activity against bacteria and
fungi, but with minimal toxicity to human cells (Fowler et al.,
2011). Moreover, it has been demonstrated that by means of com-
binatorial mutasynthesis flavonoids analogs from acrylic acids
can be produced in large and highly pure quantities using recom-
binant production platforms (Chemler et al., 2007). In that work,
Chemler and his coworkers were able to biosynthesize novel
flavanones and dihydroflavonols from a number of aromatic
acrylic acids. This once again indicated that the flavonoid network
exhibits broad substrate specificity. Mutasynthesis involves the
chemical synthesis of non-natural substrates that are similar in
structure to natural substrates. After a library of non-natural
analogs is created, enzymatic conversion of the non-natural
analogs is performed by mutated (recombinant) biocatalysts to
isolate novel non-natural compounds. The results can then be
assessed to elucidate mechanisms of enzymatic catalysis and to
determine substrate specificity requirements (Bhan et al., 2014).
This so-called semi-synthetic approach, or the combination of
chemical synthesis and biosynthesis, has also been utilized for the
production of non-natural isoflavonoids. These phytochemical
derivatives have the potential to be utilized in human therapeu-
tics, as the microbes catalyzing these novel reactions have been
isolated from the human gut and are supposed to have beneficial
health impacts on their human hosts (Cress et al., 2013).
A CURRENT UPDATE ON METABOLIC ENGINEERING DATA
APPLIED TO PHARMACOLOGICALLY AND INDUSTRIALLY
IMPORTANT FLAVONOIDS—EMPHASIS ON NOVEL AND
UNNATURAL BIOACTIVE METABOLITES
In the previous section, it has been mentioned that combina-
torial biosynthesis has been used to generate various natural
or unnatural forms of flavonoids in various microbial hosts.
Plants that can also be used as hosts have been assessed as less
advantageous compared to microbial systems, due to the exis-
tence of technical issues associated with them (Mora-Pale et al.,
2013). Biosynthesis of natural products in microbial hosts or in
plants uses energy sources derived from primary metabolism.
Shikimate metabolism feeds precursor amino acids to the phenyl-
propanoid pathway (Figure 1). Successful flux diversion from
the primary metabolism to heterologous secondary pathways
depends on many factors (host strain, nutrition media, growth
conditions etc.).
Two main approaches are applied for the production of
flavonoids in heterologous hosts. In the precursor supplementing
approach, the heterologous pathway is fed with either pheny-
lalanine or tyrosine that is then converted into the correspond-
ing flavonoid (Figure 1). Although supplementing a microbial
culture with an expensive precursor might be feasible for a
small-scale experiment, it severely impedes industrial applica-
bility. Renewable, simple and cheap carbon sources, such as
glucose and glycerol, are especially desired for the production of
pharmaceutical or any other industrial chemical or protein.
In the second approach, the engineer seeks to produce a fer-
mentation product with low needs in energy input. To achieve
this, genetic modification of the host strain is needed in order for
it to become an aromatic amino acid overproducer, thus resolving
the issue of its low initial precursor availability. During a fermen-
tation process, the available aromatic amino acids intended for
the flavonoid pathway and provided by the primary metabolism,
may not be enough to feed substantially the heterologous path-
way. The utilization of aromatic amino acid overproducers would
demonstrate optimal economic performance regarding the fer-
mentation outcome of the targeted flavonoid biosynthesis.
Currently, the most utilized biological platforms metaboli-
cally engineered for the heterologous production of flavonoids are
the microbial biofactories Escherichia coli and the budding yeast
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S. cerevisiae. The strongest argument for utilizingmicroorganisms
for metabolic engineering of natural plant products is the high
degree of their genetic tractability (Cress et al., 2013). Moreover,
numerous data sets and molecular biology tools are available
for facile genetic manipulation, characterization, modeling, and
scale-up. This genetic flexibility reduces experimental inadequa-
cies thus limiting unknown factors, and allows for faster, more
predictable experimentation and data collection. To functionally
express a set of genes for the reconstitution of a heterologous
pathway, a researcher has to deal with a series of parameters e.g.,
host selection, gene source selection, expression system, promoter
strength, plasmid/gene copy number, aeration, temperature, pH,
or nutrient supplementation. Optimization of those parame-
ters will result in improved fermentation conditions so that the
carbon flow will be optimal (Mora-Pale et al., 2013), resulting
in increased yields of the target compound at the given set of
parameters employed.
This multi-factorial approach gives space for various combina-
tions that will eventually result in a wide range of final titers. Data
from independent experiments for the biosynthesis of the fla-
vanone pinocembrin showed final flavanone titers ranging from
40 to 429mg/L (Table 1). InTable 1, reported data concerning the
heterologous production levels from various flavonoid groups can
be found. Particular effort is made to compare these titers with the
levels of those plant produced flavonoids. As discussed in the pre-
vious section, combinatorial biosynthesis protocols have recently
provided us with the opportunity to produce unnatural flavonoid
molecules (not produced from plants or any other organism).
FLAVANONES
Flavanones represent a group of compounds with very interest-
ing pharmacological properties (Ververidis et al., 2007). They are
the first synthesized flavonoid compounds, from which all other
flavonoids are generated (Figure 2). There are many examples
of constructed microbial strains that accept a relevant precursor
molecule and bio-convert it into the corresponding flavanone.
For example p-cinnamic acid, phenylalanine, and tyrosine were
converted into pinocembrin, naringenin and eriodictyol at titers
429mg/L (E. coli, Leonard et al., 2007), 8.9mg/L (S. cerevisiae,
Trantas et al., 2009), and 107mg/L (E. coli, Zhu et al., 2014)
respectively, (Table 1). In all above cases, the expression of the
implicated genes was induced and resulted in different but rel-
atively low titers. However, Leonard et al. (2007) as well as Zhu
et al. (2014), engineered their heterologous hosts by boosting pri-
mary metabolism to produce increased levels of malonyl-CoA.
In a similar set-up, E. coli was engineered to provide a pool of
malonyl-CoA needed to produce 7-O-methyl aromadendrin from
p-coumaric acid at a concentration of 2.7mg/L (Malla et al.,
2012). Extending their strategy, Zhu et al. (2014) further utilized
a truncated version of F3′Hwhich was fused with a CPR. This was
necessary as P450 classified F3′Hs require to be coupled with an
electron donor cytochrome P450 reductase (CPR), since bacteria
lack endogenous transport systems to support the full catalytic
activity of P450 enzymes (Sevrioukova et al., 1999).
However, the most interesting cases were the ones where
no precursor amino acid was supplemented and the host sys-
tems were able to utilize glucose energy for the production of
pinocembrin and naringenin, at concentrations of 40mg/L (Wu
et al., 2013) and 108.9mg/L (Koopman et al., 2012), respectively
(Table 1). In the first case, Wu and his co-workers evaluated
the use of gene encoding for feedback-insensitive enzymes to
increase the pool of intra-cellular phenylalanine. In the latter case,
Koopman and his co-workers used mutated S. cerevisiae strains,
which hindered the metabolite flow toward minor branches of
primary metabolism. More complex flavanones like sakuranetin
or ponciretin were produced at 42.5 or 40.1mg/L, respectively by
E. coli strains, when the core naringenin pathway was linked to an
O-methyltransferase (Figure 2) from rice or soybean (Kim et al.,
2013b).
FLAVONES AND FLAVONOLS
Flavones and flavonols constitute two different groups of
flavonoids. However, they are both generated by equivalent
(C2–C3) desaturation reactions in the flavonoid γ-pyrone in
the C flavonoid ring of a flavanone or flavanonol, respectively.
Enzymes FNS I (Figure 2) and FLS (Figure 3) catalyze the oxi-
dation of the respective substrates by introducing a C2–C3
double bond (Martens et al., 2003). Flavanonoles (also termed
dihydroflavonols) are the flavonoid products deriving from the
hydroxylation of flavanones at the C3 position (Figure 3). The
flavone aglycones apigenin and chrysin have been produced in
E. coli at 13 and 9.4mg/L, respectively (Miyahisa et al., 2006).
However, only apigenin glucoside was measured at 4.67mg/L
(Choi et al., 2012) (Table 1). Recently, hypolaetin, another
flavone, was produced from luteolin at 88mg/L, with the use
of a heterologous monooxygenase cloned from the bacterium
Saccharothrix espanaensis (Lee et al., 2014).
Flavonols constitute one of the most attractive groups of
flavonoids. They are two biochemical steps away from the fla-
vanones (Figure 3). Regarding their biosynthesis, a hydroxylat-
ing enzyme (Lee et al., 2014) acts on a flavanone before the
flavonol synthase acts on the generated dihydroflavonol (Holton
et al., 1993). Furthermore, types of FLS enzymes that possess
interesting bi-functional activity have been cloned from Ginkgo
biloba (Xu et al., 2012) and Citrus unshiu (Lukacin et al., 2003),
which aside from their conventional activity may act on the fla-
vanone naringenin and convert it directly into kaempferol as
demonstrated in the case of E. coli. Following steps similar to
the ones described above, various forms of flavonols have been
generated from exogenously supplemented precursor molecules.
Kaempferol and quercetin constitute well-known representatives
of this group, both produced in E. coli at concentrations of 0.3
and 0.05mg/L, respectively (Table 1), starting with p-coumaric
acid as the precursor (Leonard et al., 2006). When the full path-
way for the production of kaempferol from phenylalanine, along
with the genes leading to an increase of the internal malonyl-
CoA pool were introduced in E. coli, 15.1mg/L of the flavonol
were biosynthesized (Miyahisa et al., 2006). When a similar
approach was followed in S. cerevisiae, an amount of 1.3mg/L
of kaempferol was produced from phenylalanine (Trantas et al.,
2009). None of these compounds or any other flavonols have
been directly produced from the main feeding carbon source
(e.g., glucose) without the exogenous supplementation of any
precursor.
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Table 1 | Levels of natural flavonoid products produced either during heterologous biosynthesis in various hosts (Escherichia coli or
Sacharomyces cerevisiae), or as estimated concentrations from plant sources, (values for plant sources were retrieved from phenol-explorer
database Rothwell et al., 2013; Bhagwat et al., 2014).
Flavonoid target Plant source Metabolically Externally fed Titer References
Engineered host precursor (mg/L)
Common name
(Systematic name)
mg/100 g FW
FLAVANONES
Pinocembrin Mexican oregano
(Lippia graveolens)
499.3 E. coli Glucose 40 Wu et al., 2013
E. coli Cinnamic acid 429 Leonard et al., 2007
Eriodictyol Mexican oregano
(Lippia graveolens)
85.33 E. coli Tyrosine 107 Zhu et al., 2014
Naringenin Mexican oregano
(Lippia graveolens)
372 S. cerevisiae phenylalanine 8.9 Trantas et al., 2009
Grapefruit
(Citrus x paradisi)
53
Tomato
(Solanum lycopersicum)
3.84 S. cerevisiae Glucose 108.9 Koopman et al., 2012
Sakuranetin Mexican oregano
(Lippia graveolens)
93 E. coli Glucose 42.5 Kim et al., 2013b
Ponciretin
(isosakuranetin)
– – E. coli Glucose 40.1 Kim et al., 2013b
7-O-Methyl aromadendrin – – E.coli p-coumaric acid 2.7 Malla et al., 2012
FLAVONES
Apigenin Petroselinum crispum 302 E.coli Tyrosine 13 Miyahisa et al., 2006
Celery
(Apium graveolens)
56.25
Apigenin glucosides Mexican oregano
(Lippia graveolens)
28.33 E. coli Apigenin 4.67 Choi et al., 2012
Olea europaea 8.2
Chrysin – – E.coli Phenylalanine 9.4 Miyahisa et al., 2006
Chrysin glucosides – – E. coli Chrysin Not measurable Choi et al., 2012
Hypolaetin
(8-hydroxyluteolin)
– – E. coli Luteolin 88 Lee et al., 2014
Luteolin 4′-O-glucosides – – E. coli Luteolin 10.86 He et al., 2008
Luteolin 7-O-glucosides Mexican oregano
(Lippia graveolens)
297.67 E. coli Luteolin 6.52 He et al., 2008
Olive
(Olea europaea)
14.5
FLAVONOLS
Kaempferol (Capers)
Capparis spinosa
104.29 E.coli Dihydrokaempferol n.e. Xu et al., 2012
E.coli Naringenin n.e. Xu et al., 2012
E.coli Naringenin n.e. Lukacin et al., 2003
(Continued)
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Table 1 | Continued
Flavonoid target Plant source Metabolically Externally fed Titer References
Engineered host precursor (mg/L)
Common name
(Systematic name)
mg/100 g FW
Anethum
(Anethum graveolens)
26.7 E.coli p-Coumaric acid 0.3 Leonard et al., 2006
S. cerevisiae Phenylalanine 1.3 Trantas et al., 2009
E. coli kaempferol 28.6 Kim et al., 2006
E. coli Phenylalanine 15.1 Miyahisa et al., 2006
Kaempferol
3-O-glucoside (Astragalin)
Bean
(Phaseolus vulgaris)
39.88 E. coli Kaempferol 13.56 (He et al., 2008)
E. coli Naringenin 109.3 Malla et al., 2013
Quercetin (Capers)
Capparis spinosa
32.82 E.coli p-Coumaric acid 0.05 Leonard et al., 2006
S. cerevisiae Phenylalanine Traces Trantas et al., 2009
E. coli Quercetin 30.2 Kim et al., 2006
Quercetin 3-O-glucoside Bean
(Phaseolus vulgaris)
6 × 10−3 E. coli Quercetin 11.54 He et al., 2008
3-O-Xylosyl quercetin – – E. coli Quercetin 23.78 Pandey et al., 2013
Kaempferol-3-O-
rhamnoside
Endive
(Cichorium endivia)
0.16 E. coli Kaempferol 150 Kim et al., 2012b
Quercetin-3-O-
rhamnoside
Lingonberry
(Vaccinium vitis-idaea)
12.2 E. coli Quercetin 200 Kim et al., 2012b
Olive
(Olea europaea)
4.1
ISOFLAVONONES
Genistein Soy
(Glycine max)
30.76 E. coli Naringenin 16.2 Kim et al., 2009
S. cerevisiae Naringenin n.e. Akashi et al., 1999
E. coli—S. cerevisiae
Co-cultivation
Tyrosine 6 Katsuyama et al.,
2007b
E. coli Naringenin 10mg/g Leonard and Koffas,
2007
S. cerevisiae Phenylalanine 0.1 Trantas et al., 2009
Genistein glucosides – – E. coli Genistein 37.29 Pandey et al., 2014
Genistin Soy
(Glycine max)
2.22 S. cerevisiae Genistein n.e. Li et al., 2014
Daidzein Soy
(Glycine max)
13 E. coli Liquiritigenin 18mg/g Leonard and Koffas,
2007
3′-Hydroxydaidzein – – E. coli Daidzein 75 Lee et al., 2014
Daidzin Soy
(Glycine max)
1.27 S. cerevisiae Daidzein n.e. Li et al., 2014
Ononin – – S. cerevisiae Formononetin n.e. Li et al., 2014
Sophoricoside – – E. coli Genistein n.e. Ruby et al., 2014
For structure details and metabolic steps see Figures 2, 3.
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FIGURE 3 | Late biosynthetic steps of flavonoid metabolism
downstream of flavanones (Continuation of Figure 2);
Dihydroflavonols are created by a flavanone 3β–hydroxylase (F3H)
acting on flavanones that are transformed into flavonols by the
action of a flavonol synthase (FLS) (Ververidis et al., 2007). The
group of isoflavones is created by the action of an isoflavone synthase
(IFS) on flavanones. MT, methyltransferase; GT, glucoside transferase;
Sam5, microbial C3H (Lee et al., 2014); CYP105D7, flavonoid 3′
hydroxylase; F3′H, flavonoid 3′ hydroxylase; F3′5′H, flavonoid 3′ and 5′
hydroxylase; IOMT, isoflavone 4′-O-methyl transferase.
Moreover, various forms of flavonols have been generated by
the action of various decorating enzymes. A common biotransfor-
mation is the attachment of sugars to the hydroxyl groups of the
flavonoid backbone through the action of glycosyl-transferases
(Figure 3). Following this method, E. coli strains were capable
of producing astragalin at 109.3mg/L from naringenin (Malla
et al., 2013) or 13.56mg/L from kaempferol (He et al., 2008)
and 23.78mg/L of 3-O-xylosyl quercetin from quercetin (Pandey
et al., 2013), (Table 1). Other similar attempts to obtain glycosyl-
transferases from various sources include the biotransformation
of apigenin, chrysin, luteolin, kaempferol, and quercetin to their
3-O-, 7-O-, or 4′-O-glucosides (He et al., 2008; Choi et al., 2012).
The utilization of a rhamnose flavonol glycosyltransferase on
kaempferol and quercetin was adequate for the production of
the corresponding 3-O-rhamnosides at concentrations of 150 and
200mg/L, respectively (Kim et al., 2012b).
ISOFLAVONONES
Isoflavonoids are mostly known thanks to their interaction with
the human and animal estrogen receptors (Cress et al., 2013).
It is not a uni-variate class of compounds but rather consists of
more than one subclasses (e.g., isoflavones, isoflavanes) which are
modified in later steps (Dixon and Steele, 1999); more than 1600
isoflavonoid derivatives have been identified to date (Pandey et al.,
2014). As with other classes, E. coli and S. cerevisiae are the most
common hosts for heterologous production of isoflavonoids. The
main reaction in the biosynthesis of isoflavonoids is the region-
specific movement of the flavonoid B-ring from the C-2 to the
C-3 position by the action of the P450 enzyme isoflavone synthase
(IFS, Figure 3) (Pandey et al., 2011).
The first attempt to transform a flavanone into the corre-
sponding isoflavanone in microbes was accomplished by Akashi
et al. (1999), who expressed an IFS gene from licorice in yeast
cells to transform naringenin into genistein. In their work, the
requirement for a CPR was covered by endogenous yeast reduc-
tases. In an alternative approach, Kim et al. (2009) managed to
produce genistein in E. coli. In that case, the IFS from red clover
was engineered to fuse in-frame with a CPR cloned from rice.
The resulted protein could readily convert naringenin into genis-
tein at up to 15.1mg/L (Table 1). When Leonard et al. (2009)
expressed an engineered chimeric IFS in E. coli, they enabled the
robust production of genistein and daidzein from the supple-
mented naringenin and liquiritigenin at concentrations of 10 and
18mg/g, respectively. The engineered IFS was constructed as a
fusion of the IFS cloned from Glycine max with the CPR cloned
from Catharanthus roseus, from which the membrane spanning
hydrophobic regions were removed and a mammalian leader
sequence was added. In a different approach, the implementation
of a co-cultivation of E. coli and S. cerevisiae strategy, where the
naringenin produced by E. coli was transformed into genistein by
S. cerevisiae cells carrying an IFS gene, led to the production of up
to 6mg/L of genistein (Katsuyama et al., 2007b).
The conversion rate of a precursor to the final product may be
high when referring to mono-enzymatic reactions. However, this
does not always apply to cases of multi-enzyme reactions. Trantas
et al. (2009) attempted to reconstruct the whole biosynthetic
pathway for the biosynthesis of genistein in S. cerevisiae by intro-
ducing seven genes under GAL promoters. When the production
system was supplied with phenylalanine, yeast cells transformed
with the full pathway produced 0.1mg/L of genistein. When the
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same system was supplied with p-coumaric acid or naringenin,
0.14 or 7.7mg/L of genistein were produced (Table 1), indicat-
ing rate limiting steps or a diversion of the metabolic flux toward
genistein from upstream metabolic steps.
Furthermore, glycosylated variants of isoflavonoids have been
successfully produced via the utilization of different glycosyl-
transferases cloned from various sources, in order to develop
new biological activities. As a result, genistein, daidzein, or for-
mononetin have been successfully transformed into daidzin,
genistin, or ononinin in S. cerevisiae cells through the utilization
of a glycosyl-transferase from Pueraria lobata (Li et al., 2014) or
in E. coli through the utilization of a glycosyl-transferase deriv-
ing from Bacillus licheniformis (Pandey et al., 2014), or from
Glycyrrhiza echinata (Nagashima et al., 2004) (Figure 3, Table 1).
Sophoricoside, a 4′ glucoside of genistein was produced in E. coli
when a glycosyl-transferase from Bacopa monniera was utilized
(Ruby et al., 2014). Recently, 3′- hydroxydaidzein was produced
at 75mg/L from daidzein with a heterologous monooxygenase
cloned from the bacterium S. espanaensis (Lee et al., 2014).
Equol constitutes another interesting example of the
isoflavonoids (isoflavan subclass). It exhibits biological prop-
erties that exceed those of its precursor daidzein and can be
used as pharmaceutical or nutraceutical agent for a number
of hormone-dependent disorders due to its resemblance with
the human hormone estradiol (Setchell and Clerici, 2010b).
While much of the interest in equol is centered around its
estrogenic effects, there are many other biological properties with
potential to be of value in treating diseases in many clinical areas,
including cancer, cardiovascular disease, osteoporosis, as well as
menopausal symptoms (Setchell et al., 2002). Another interesting
member of the isoflavan group is 5-hydroxy-equol, also exhibit-
ing increased antioxidant activity compared to its precursor
genistein (Schroder et al., 2013). Both those isoflavans cannot
be biosynthesized in nature but are encountered as daidzein or
genistein byproducts after the action of gut micro-flora (Setchell
and Clerici, 2010a). Recently, the genes responsible for their
metabolism were identified from Slackia isoflavoniconvertens and
functionally expressed in E. coli (Schroder et al., 2013).
UNNATURAL FLAVONOIDS
Although flavonoids have been studied extensively, so far we
have only discussed natural compounds that can be found in
nature. However, as mentioned above, host organisms possess
the ability to bioconvert unusual molecules they are fed exter-
nally, to produce non-native, thus termed, unnatural flavonoids.
Even though plants do not produce these compounds at all, they
seem very promising for the pharmaceutical industry thanks to
their properties. In some cases, interesting unnatural flavonoids
can be produced that may exhibit numerous pharmacological
properties, examples being the cases of flavonols (Forbes et al.,
2014), bichalcones (Gurung et al., 2010) or flavonoidal alkaloids
(Nguyen et al., 2012). Such approaches open the way to the devel-
opment of new strategies that can lead to the biosynthesis of novel
unnatural bioactive compounds.
Among the first attempts to produce unnatural flavonoids,
Chemler et al. (2007) managed to transform various cin-
namic and acrylic acid analogs into the corresponding decorated
flavonoids or flavonols (Figure 4) through the use of engineered
S. cerevisiae strains containing a set of core flavonoid genes.
They relied on the broad substrate specificity of the utilized
genes that were able to biotransform the supplied precursor
molecules through sequential enzymatic activities, producing
unnatural flavanones at titers of 2.81 to 15.82mg/L (Table 2).
A similar approach was used by Katsuyama et al. (2007a), who
succeeded in producing an array of 36 unnatural flavonoids
(16 of which are novel in bibliography) that belong to the
classes of flavanones (45–102mg/L), flavones (26–46mg/L), and
flavonols (0.5–33mg/L). Katsuyama et al. (2007a) used recom-
binant E. coli bearing selected genes from the phenylpropanoid
pathway to direct the construction of appropriate novel natural
and unnatural plant analogs of flavonoids and polyketides when
fed with various precursor molecules. These analogs of flavones
and flavonols were biosynthesized from their respective natural
or unnatural carboxylic acids, which served as precursors for the
action of post-polyketide modification enzymes, such as flavones
synthase I (FNSI) and flavanone 3-hydroxylase/flavonol synthase
(F3H/FLS), respectively (Figures 2, 3).
The construction of bacterial strains for the synthesis of
unnatural flavonoid glycosides possessing interesting properties
is possible through rationally designed approaches. This strategy
involves the design of new molecules with a specific functional-
ity, based on the ability to predict how the molecule’s structure
will affect its behavior through physical models. An interesting
case was the use of a combination of glycosyl transferases to
attach more than one glycosyl groups in the hydroxyl groups
of the flavonoid backbone (diglycosides). In accordance with
this idea, specific UGTs were expressed in E. coli for the pro-
duction of 67mg/L of quercetin 3-O-glucoside-7-O-rhamnoside
and 67.4mg/L of quercetin 3,7-O-bisrhamnoside (Kim et al.,
2013a) (Figure 4, Table 2). The selection of a nucleotide specific
glycosyl-transferase (UGT) and its expression into E. coli cells
made the biosynthesis of the unnatural glycosylated quercetin
analog, quercetin 3-O-6-deoxytalose (Yoon et al., 2012) pos-
sible. Moreover, an E. coli strain was engineered to produce
7-O-xylosyl naringenin when fed with naringenin (Simkhada
et al., 2009). The strain was constructed through the overexpres-
sion of genes required for the biosynthesis of UDP-xylose as well
as the 7-O-glycosyltransferase gene. Following a similar approach,
Kim et al. (2012a) managed to produce 380mg/L of quercetin
3-O-N-acetylglucosamine when the engineered E. coli strain was
fed with quercetin. Methyl transferases have also been used for the
production of methylated forms of flavonoids. The co-cultivation
of a strain carrying an FLS gene and a strain carrying a 3-OMT
successfully transformed the supplemented dihydrokaempferol
or dihydroquercetin into kaempferol and quercetin respectively
(Kim et al., 2010). Novel methyl-transferases for the methylation
of an extra position of the flavonol backbone have also been engi-
neered; 3,7-O-dimethylquercetin and 3,7-O-dimethylkaempferol
were produced in E. coli at concentrations of 19.16 and 22mg/L
(Joe et al., 2010).
DYNAMIC PATHWAY REGULATION AND METABOLIC
CONTROL
Traditional metabolic engineering is largely focused on the
over-expression of rate-limiting steps (Tai and Stephanopoulos,
2013), deletion of competing pathways (Stephanopoulos, 2012),
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FIGURE 4 | Heterologous biosynthesis of unnatural flavonoids in E. coli
host. Various unnatural hydroxyncinnamic acids and their analogs are utilized
for the generation of various unnatural flavanones, flavones, dihydroflavonols,
and flavonols. Data were collected from various publications shown by
bracketed numbers (1, Simkhada et al., 2009; 2, Yoon et al., 2012; 3, Joe
et al., 2010; 4, Kim et al., 2010; 5, Chemler et al., 2007; 6, Katsuyama et al.,
2007a). Arrows indicate the course of the biosynthetic pathway. Implicated
enzymes: 4CL, hydroxycinnamic acid:CoA ligase; CHS, chalcone synthase;
CHI, chalcone isomerase; FNS I, flavone synthase I; MT, methyltransferase;
GT, glucoside transferase.
managing ATP (Singh et al., 2011; Lan and Liao, 2012) and
balancing redox and precursor metabolites (Singh et al., 2011).
While these approaches have been proven effective in improv-
ing cellular productivity and yield, the engineered strains are
often incapable of dynamically controlling gene expression and
are susceptible to environmental perturbations. As heterolo-
gous pathways become larger and more complicated, it becomes
increasingly difficult to optimize them with static regulatory con-
trol (Holtz and Keasling, 2010). Generally, optimization through
static control is only applicable in a particular environment
and any perturbations that are away from the prescribed condi-
tion would likely result in phenotype instability or suboptimal
productivity.
Contrary to static control, native biological systems typically
utilize dynamic regulatory networks to control metabolic flux in
response to changing environments (Xu et al., 2013a). For exam-
ple, one of the coherent strategies that occur in most biological
systems is gene expression regulation through a negative/positive
feedback loop (Afroz and Beisel, 2013). Mediated by a tran-
scriptional regulator, a metabolic intermediate would act as a
signaling molecule which would induce or repress the expression
of enzymes responsible for its synthesis or consumption. Nature
has developed this strategy in order to allow metabolic path-
ways to be dynamically controlled so that cellular resources can
be efficiently utilized, regardless of the changing environment.
In practice, this strategy could be applied to pathway optimiza-
tion when accumulated toxic intermediates are detrimental to cell
growth. Successful application of this optimization strategy would
require the construction of hybrid promoters that are transcrip-
tionally responsive to small intermediate molecules (Xu et al.,
2014b). For example, Liao et al have designed and applied a reg-
ulatory circuit that could sense the glycolytic pathway hallmark
metabolite acetyl-phosphate to control the lycopene biosynthetic
pathway (Farmer and Liao, 2000) and generate oscillatory gene
expression (Fung et al., 2005) as well as achieve artificial cell-cell
communication (Bulter et al., 2004). Dhal et al. have employed
stress-response promoters to improve farnesyl pyrophosphate
production (Dahl et al., 2013) and Zhang et al. have constructed a
fatty acyl-CoA responsive promoter to dynamically control gene
expression involved in biodiesel synthesis (Zhang et al., 2012) in
E. coli.
Recently, Xu et al. (2014a,b) have reported a genetically-
encoded metabolic switch that enables dynamic regulation
of both the malonyl-CoA source pathway and the malonyl-
CoA sink pathway (Figure 5). Engineering hybrid promoter-
transcriptional regulator interactions led to the construction
of two malonyl-CoA sensors that exhibit opposing transcrip-
tional activities. Proper balancing of the transcriptional activity
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Table 2 | Levels of unnatural flavonoid products obtained using metabolically engineered E. coli and Saccharomyces cerevisiae hosts.
Flavonoid target Engineered Externally fed precursor Titer References
organism (mg/L)
FLAVANONES
7-O-Xylosyl naringenin E. coli Naringenin n.e. Simkhada et al., 2009
(2S)-2-(4-fluorophenyl)-5,7-dihydroxy-2,3-
dihydro-1-benzopyran-4-one
(2E)-3-(4-fluorophenyl)prop-2-enoic acid 102 Katsuyama et al., 2007a
(2S)-2-(furan-3-yl)-5,7-dihydroxy-3,4-dihydro-
2H-1-benzopyran-4-one
(2E)-3-(furan-3-yl)prop-2-enoic acid hydrate 53 Katsuyama et al., 2007a
(2S)-5,7-dihydroxy-2-(thiophen-3-yl)-3,4-
dihydro-2H-1-benzopyran-4-one
(2E)-3-(thiophen-3-yl)prop-2-enoic acid hydrate 45 Katsuyama et al., 2007a
(2S)-3′-5,7-trihydroxyflavanone m-Coumaric acid 6.54 Chemler et al., 2007
(2S)-2′,5,7-trihydroxyflavanone o-Coumaric acid 6.36 Chemler et al., 2007
(2S)-5,7-dihydroxy-4′-fluoroflavanone p-Fluorocinnamic acid 2.81 Chemler et al., 2007
(2S)-5,7-dihydroxy-2′-fluoroflavanone o-Fluorocinnamic acid 6.54 Chemler et al., 2007
(2S)-4′-amino-5,7-dihydroxyflavanone p-Aminocinnamic acid 15.82 Chemler et al., 2007
FLAVONOLS
Quercetin 3-O-(6-deoxytalose) E. coli Quercetin 98 Yoon et al., 2012
3-O-Methyl kaempferol Naringenin 22.5 Kim et al., 2010
3,7-O-Dimethyl quercetin Quercetin 19.2 Joe et al., 2010
3,7-O-Dimethyl kaempferol Kaempferol 22 Joe et al., 2010
Quercetin 3-O-N-acetylglucosamine Quercetin 380 Kim et al., 2012a
Quercetin 3-O-glucoside-7-O-rhamnoside Quercetin 67 Kim et al., 2013a
3,7-O-bisrhamnoside Quercetin 67.4 Kim et al., 2013a
2-(4-fluorophenyl)-3,5,7-trihydroxychromen-4-
one
(2E)-3-(4-fluorophenyl)prop-2-enoic acid Trace Katsuyama et al., 2007a
(2S)-3′-5,7-trihydroxy-dihydroflavonol S. cerevisiae m-Coumaric acid 2.98 Chemler et al., 2007
(2S)-2′,5,7-trihydroxy-dihydroflavonol o-Coumaric acid 3.85 Chemler et al., 2007
(2S)-5,7-dihydroxy-4′-dihydroflavonol p-Fluorocinnamic acid 0.75 Chemler et al., 2007
(2S)-5,7-dihydroxy-2′-fluoro-dihydroflavonol o-Fluorocinnamic acid 4.5 Chemler et al., 2007
(2S)-4′-amino-5,7-dihydroxy-dihydroflavonol p-Aminocinnamic acid 10.44 Chemler et al., 2007
ISOFLAVONES
3′,4′,7-Trihydroxy isoflavone E. coli Daidzein n.e. Roh, 2013
FLAVONES
2-(4-fluorophenyl)-5,7-dihydroxy-4H-chromen-
4-onebenzopyran-4-one
E. coli (2E)-3-(4-fluorophenyl)prop-2-enoic acid 30 Katsuyama et al., 2007a
2-(furan-3-yl)-5,7-dihydroxy-4H-chromen-4-one (2E)-3-(furan-3-yl)prop-2-enoic acid hydrate 26 Katsuyama et al., 2007a
5,7-dihydroxy-2-(thiophen-3-yl)-4H-chromen-4-
one
(2E)-3-(thiophen-3-yl)prop-2-enoic acid hydrate 46 Katsuyama et al., 2007a
For structure details and metabolic steps see Figure 4.
of the malonyl-CoA-up regulating promoter and malonyl-CoA-
down regulating promoter resulted in an integrated malonyl-CoA
switch rendering a bi-stable gene expression pattern. When this
synthetic malonyl-CoA switch was implemented to control fatty
acids production, the engineered strain could better balance the
tradeoff between cell growth and product formation and demon-
strated superior FA production profile. The control scheme in
this study is the first report to use both the ON and OFF func-
tion to regulate cell metabolism. Unlike the report by Zhang et al.
(2012) and Xu et al. (2014a,b) only used an “ON” function to
control the expression of the fatty acid ethyl ester (FAEE) down-
stream pathway (fatty acyl-CoA and ethanol synthesis), where the
FAEE upstream pathway (fatty acids synthesis) was left uncon-
trolled. Since malonyl-CoA is an essential precursor involved in
the biosynthesis of flavonoids, polyketides and fatty acids-based
biofuels (Xu et al., 2011, 2013b; Felnagle et al., 2012), the synthetic
malonyl-CoA switch should facilitate the construction of strains
for high yield production of malonyl-CoA-derived compounds.
METABOLOMICS AND NGS ASSISTED BIOINFORMATICS
FOR PATHWAY MINING
The vicious interaction between evolution and nature, equipped
all organisms with appropriate genetic machinery to biosynthe-
size accessories of secondary metabolism, in order to withstand
the pitfalls of their life cycle. Although part of this machinery has
been identified, various parts remain uncovered. As analyzed ear-
lier, all these secondary metabolites evolved from interconnected
biosynthetic paths and followed various tailoring, condensing and
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FIGURE 5 | Schematic representation of syntheticmalonyl-CoA controller
for dynamic tuning of metabolic flux in E. coli (Xu et al., 2014a). FapR
activates geneexpression frompGAP promoter and represses geneexpression
fromT7promoter at low level ofmalonyl-CoA.BindingofFapRwithmalonyl-CoA
will switch gene source pathway (ACC) to malonyl-CoA sink pathway (FAS).
FapR: malonyl-CoA responsive Bacillus subtilis fatty acids pathway
transcriptional regulator; Mal-CoA, malonyl-CoA; FAS, fatty acids synthase;
ACC, acetyl-CoA carboxylase; pGAP, E. coli GAPpromoter; T7, bacteriophage T7
promoter; fapO, putative FapR binding site; lacO, putative lacI repressor binding
site. Point arrows indicate activation and blunt-end arrows indicate repression.
decorating enzymatic interventions, which are responsible for
their eventual categorization into phenylpropanoids, flavonoids,
alkaloids, terpenoids, etc. In most of these biosynthetic pathways,
core enzymes exist to put key biochemical reactions through for
the production of the final product. The core enzymes of the
flavonoid biosynthetic pathways are responsible for the produc-
tion of the basal flavonoid skeleton. However, there is a plethora
of other tailoring enzymes for the decoration of the core skele-
ton with extra chemical patterns differing in oxidation, acylation,
methylation, or glycosylation patterns. Those are achieved by
utilizing the oxido-reductases and acyl- or glycosyl-transferases
available creating the different flavonoid classes—as described
above, consisting of the overabundance of flavonoid compounds.
Emerging technologies in the fields of Metabolomics and
Genomics offer massive assistance in the quest for new enzyme
activities or even new metabolic pathways. On the one hand,
improved mass spectrometry apparatuses let users identify chem-
ical entities, and even extrapolate native intracellular concentra-
tions. Such techniques coupled with processes for monitoring of
metabolic transformations have allowed metabolomics to thrive
within the context of enzyme function or pathway discovery in
model or non-model organisms (Prosser et al., 2014).
On the other hand, the emergence of Next-Generation
Sequencing technologies (NGS) has revolutionized functional
genomics. Entire microbial genomes can now be sequenced, facil-
itating the discovery of biosynthetic gene clusters. The conserved
features of the flavonoid core and decorating enzymes, that inter-
act in such a manner to create flavonoid metabolons (Winkel,
2004; Crosby et al., 2011), may be used as queries in computer
programs that compare primary biological sequence informa-
tion to find matches (Altschul et al., 1990). This will help us
to mine homolog flavonoid pathways in other species or indi-
viduals in general. The rapidly evolving NGS technologies (Hui,
2014) result in the loading of public databases with enormous
amounts of organismal sequence data surpassing manual anno-
tations. Having gigabases of data in their hands combined with
metabolic profiling, functional genomics and system biology
approaches, scientists can routinely examine in-silico and obtain
in-depth knowledge in their attempt to further understand the
flavonoid biosynthetic pathways. This may increase the potential
of bio-engineering through identification of putative genes cod-
ing for enzymes with improved or novel activities involved in the
flavonoid pathways. Along this line of reasoning, we should also
note that deep transcriptome sequencing and metabolic profiling
have allowed the identification of gene variants for anthocyanin
biosynthesis in Camellia chekiangoleosa (Wang et al., 2014) and
flavonoids and terpenoids biosynthesis in Isatis indigotica (Chen
et al., 2013). Whenever lack of genomic information or devel-
oped genetic tools presents itself, the exploration of the molec-
ular mechanism of flavonoid formation is faced with difficulties.
Transcriptome sequencing can be an efficient approach to obtain-
ing functional genomic information, which could contribute to
pathway mining. Furthermore, generated NGS data will serve as
information platforms for gene expression, genomics, and func-
tional genomics. Efficient data analysis pipelines are required for
all these applications in order for them to be established as rou-
tine activities, and more studies are needed aiming to address
the robustness of these techniques (Morozova and Marra, 2008).
Automated annotation needs to be as accurate as possible to
avoid systematic errors generated by misjudging gene callings
(Bakke et al., 2009). In other words, although sequencing has
become easy, genome annotation has become more challeng-
ing: (a) NGS technologies yield short read lengths resulting in
loss of contiguity, (b) sequencing of “exotic” genomes without
pre-existing user-centric annotation data renders predictive gene-
calling methods hard to train, optimize and configure (Yandell
and Ence, 2012). Although genome annotation is not a point-
and-click procedure, “do-it-yourself” projects are feasible using
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present-day tools. This has also allowed the discovery of a new
range of enzymatic diversities, entirely new sequence classes and
novel functionalities (Pollier et al., 2011).
CONCLUDING REMARKS
Flavonoids constitute a diverse group of secondary plant metabo-
lites with fascinating compounds that display extraordinary
antioxidant activity. Many of these compounds are used as phar-
maceutical drugs or as nutraceutical supplements. Flavonoid
engineering has greatly progressed over the past few years.
Technical advances in gene discovery, functional genomics and
the large-scale implementation of different combinatorial biosyn-
thesis techniques in plants all promise a bright green future for the
discovery and exploitation of plant derived products. Moreover,
algorithmic tools, such as the software package OptForce, are
already available to help researchers perform targeted genetic
interventions in order to increase carbon flux through malonyl-
CoA (Bhan et al., 2013). This is indeed the limiting precursor
step for the overexpression of an array of heterologous pathways
such as flavanones and polyketides in bacteria. Koffas’ group has
developed a sensor that manipulates two cellular pathways that
regulate production of malonyl-CoA (Xu et al., 2014a) in real
time. By utilizing the sensor-based dynamic regulation technique
at the cellular level, researchers were able to maximize production
of malonyl-CoA while minimizing any damage to the cell. This
technique has been applied to fatty acid biosynthesis and seems
very promising for flavonoids, since, by improving malonyl-CoA
availability in E. coli, natural plant product titers can be improved
as well. An alternative or a parallel approach would be to iden-
tify and exploit microorganisms that overproduce phenylalanine
or tyrosine to minimize the input of carbon source during the
fermentation procedure.
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